Journal of Gastroenterology

, Volume 30, Issue 3, pp 416–427 | Cite as

Pathologic basis of gastric mucosal adaptation to topical injury

  • Jerzy Stachura
  • Stanisław J. Konturek
  • Tomasz Brzozowski
  • Jan Konturek
  • Wolfram Domschke


Public Health Internal Medicine Pathologic Basis Topical Injury Mucosal Adaptation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Farber J. Membrane injury and calcium homeostasis in the pathogenesis of coagulative necrosis. Lab Invest 1982;47: 114–122.PubMedGoogle Scholar
  2. 2.
    Slater TF. Free radical mechanisms in tissue injury. Biochem J 1984;222:1–12.PubMedGoogle Scholar
  3. 3.
    Stachura J. Pathomorphology of gastric mucosal injury. In: Hollander D, Tarnawski A (eds) Gastric cytoprotection. A clinician's guide. New York: Plenum Medical Book Co, 1989;33–48.Google Scholar
  4. 4.
    Stachura J, Dabroś W, Tarnawski A. Physiological cell loss in the gastric oxyntic mucosa in the rat by the process of apoptosis. An ultrastructural observation. Exp Clin Gastroenterol 1991;1:151–163.Google Scholar
  5. 5.
    Stachura J, Tarnawski A, Dabroś W. Apoptosis: Genetically programmed physiologic cell loss in normal gastric oxyntic mucosa and in mucosa of grossly healed gastric ulcer. J Clin Gastroenterol 1993;17:S70-S77.PubMedGoogle Scholar
  6. 6.
    Ito S, Lacy ER. Morphology of rat gastric mucosal damage. Defence and restitution in the presence of luminal ethanol. Gastroenterology 1985;88:250–260.PubMedGoogle Scholar
  7. 7.
    Lacy ER. Gastric mucosal resistance to a repeated ethanol insult. Scand J. Gastroenterol 1985;20(Suppl 1):63–72.Google Scholar
  8. 8.
    Lacy ER, Cowart KS, Hund P. Effect of chronic superficial injury on the rat gastric mucosa. Gastroenterology 1992; 103:1179–1191.PubMedGoogle Scholar
  9. 9.
    Lev R, Siegiel HI, Glass GBJ. Effects of salicylates on the canine stomach: A morphological and histochemical study. Gastroenterology 1972;62:970–980.PubMedGoogle Scholar
  10. 10.
    Levi S, Goodlad RA, Lee CY, et al. Effects of nonsteroidal anti-inflammatory drugs and misoprostol on gastroduodenal epithelial proliferation in arthritis. Gastroenterology 1992; 102:1605–1611.PubMedGoogle Scholar
  11. 11.
    Ivey KJ. Mechanisms of NSAID-induced gastric damage; actions of therapeutic agents. Am J Med 1988;84(Suppl 2A): 41–48.PubMedGoogle Scholar
  12. 12.
    Whittle BJR. The potentiation of taurocholate-induced rat gastric erosions following parenteral administration of cyclooxygenase inhibitors. Br J Pharmacol 1983;80:545–551.PubMedGoogle Scholar
  13. 13.
    Rees DW, Gibons LC, Turnberg LA. Effect of NSAIDs and prostaglandins on alkali secretion by rabbit fundus in vitro. Gut 1983;24:784–789.PubMedGoogle Scholar
  14. 14.
    Kitahora T, Guth PH. Effect of aspirin plus hydrochloric acid on the gastric mucosa microcirculation. Gastroenterology 1987;93:810–817.PubMedGoogle Scholar
  15. 15.
    Ashley SW, Sonnenschein LA, Cheung LY. Focal gastric mucosa blood flow at the site of aspirin-induced ulceration. Am J Surg 1985;149:53–59.PubMedGoogle Scholar
  16. 16.
    Sandor Z, Szabo S. Pharmacologic approaches and pathogenic basis for NSAID gastropathy, prevention and treatment. Proc Gastroenterol 1991;15:30–43.Google Scholar
  17. 17.
    McCarthy DM. Nonsteroidal anti-inflammatory drug-induced ulcers: Management by traditional therapies. Gastroenterology 1989;96:662–674.PubMedGoogle Scholar
  18. 18.
    Wallace JL, Keenan CM, Granger DN. Gastric ulceration induced by nonsteroidal anti-inflammatory drugs is a neutrophil-dependent mechanism. Am J Physiol 1990;259: G462-G467.PubMedGoogle Scholar
  19. 19.
    Wallace JL, Hogaboam CM, Kubes P. Immunopathology of NSAID-gastropathy: Inhibitory effects of interleukin-1 and cyclosporin A. Ann N Y Acad Sci 1992;664:400–407.PubMedGoogle Scholar
  20. 20.
    Wallace JL. Non-steroidal anti-inflammatory drug gastropathy and cytoprotection. Pathogenesis and mechanisms re-examined. Scand J Gastroenterol 1992;27(Suppl 192):3–8.Google Scholar
  21. 21.
    Trevethick MA, Clayton NM, Strong P, et al. Do infiltrating neutrophils contribute to the pathogenesis of indomethacin-induced ulceration of the rat gastric antrum. Gut 1993;34: 156–160.PubMedGoogle Scholar
  22. 22.
    Graham DY, Smith JL, Dobbs SM. Gastric adaptation occurs with aspirin administration in man. Dig Dis Sci 1983;28:1–6.PubMedGoogle Scholar
  23. 23.
    Olivero JL, Graham DY. Gastric adaptation to nonsteroidal anti-inflammatory drugs in man. Scand J Gastroenterol 1992;27(Suppl 193):53–58.Google Scholar
  24. 24.
    Eastwood GL, Quimby GF. Effect of chronic aspirin ingestion on epithelial cell proliferation in rat fundus, antrum and duodenum. Gastroenterology 1982;82:852–856.PubMedGoogle Scholar
  25. 25.
    Kuwayama H, Eastwood G, Miyake S, et al. Adaptation of gastric mucosa to repeated indomethacin administration in the rat (abstract). Gastroenterology 1986;90:A1506.Google Scholar
  26. 26.
    Graham DY, Smith JL, Spjut HJ, et al. Gastric adaptation. Studies in humans during continuous aspirin administration. Gastroenterology 1988;85:327–333.Google Scholar
  27. 27.
    Stachura J, Konturek J, Dembiński A, et al. Do infiltrating leuckocytes contribute to the adaptation of human gastric mucosa to continued aspirin administration? Scand J Gastroenterol 1994;29:966–972.PubMedGoogle Scholar
  28. 28.
    Ivey KJ, Tarnawski A, Stachura J, et al. The induction of gastric mucosal tolerance to alcohol by chronic administration. J Lab Clin Med 1980;96:922–932.PubMedGoogle Scholar
  29. 29.
    Tarnawski A, Lu S-Y, Stachura J, et al. Adaptation of gastric mucosa to chronic alcohol administration is associated with increased mucosal expression of growth factors and their receptors. Scand. Gastroenterol 1992;27(Suppl 193):59–63.Google Scholar
  30. 30.
    Whitehead R. Mucosal biopsy of the gastrointestinal tract. Philadelphia: WB Sauders, 1990;84–86.Google Scholar
  31. 31.
    Dinoso VP Jr, Chey WY, Braverman SP, et al. Gastric secretion and gastric mucosal morphology in chronic alcoholics. Arch Int Med 1972;130:715–719.Google Scholar
  32. 32.
    Brown RC, Hardy GJ, Temperly JM, et al. Gastritis and cirrhosis: No association. J Clin Pathol 1981;34:744–748.PubMedGoogle Scholar
  33. 33.
    Morson BC, Dawson IMP. Gastrointestinal pathology. Oxford: Blackwell Scientific, 1990;94–96.Google Scholar
  34. 34.
    Quinn CM, Bjarnason I, Price AB. Gastritis in patients on non-steroidal anti-inflammatory drugs. Histopathology 1993; 23:341–348.PubMedGoogle Scholar
  35. 35.
    Robert A, Kauffman GL. Stress ulcers. In: Sleisenger MH, Fordtran JS (eds) Gastrointestinal diseases, pathophysiology, diagnosis, management. Philadelphia: Saunders, 1983;612–662.Google Scholar
  36. 36.
    Moody FG, Cheung LY, Simons MA, et al. Stress and the acute gastric mucosal lesions. Dig Dis 1976;21:148–154.Google Scholar
  37. 37.
    Hase T, Anderson RP, Mehlman B. Significance of gastric secretory changes in the pathogenesis of stress ulcer. Am J Dig Dis 1975;20:1197–1198.CrossRefGoogle Scholar
  38. 38.
    Hayase M, Takeuchi K. Gastric acid secretion and lesion formation in rats under water-immersion stress. Dig Dis Sci 1986;31:166–171.CrossRefPubMedGoogle Scholar
  39. 39.
    Konturek PK, Brzozowski T, Konturek SJ, et al. Role of epidermal growth factor, prostaglandin and sulfhydryls in stress-induced gastric lesion. Gastroenterology 1990;99: 1607–1615.PubMedGoogle Scholar
  40. 40.
    Konturek SJ, Brozowski T, Konturek PK, et al. Role of salivary glands and epidermal growth factor (EGF) in gastric secretion and mucosal integrity in rats exposed to stress. Reg Pept 1991;32:203–215.CrossRefGoogle Scholar
  41. 41.
    Garrick T, Buack S, Bass P. Gastric motility is a major factor in cold restraint-induced lesion formation in rats. Am J Physiol 1986;250:G191-G199.PubMedGoogle Scholar
  42. 42.
    Basson N, Materia A, Forlini A, et al. Prostaglandin generation in the gastric mucosa of rats with stress ulcer. Surgery 1983;94:104–108.Google Scholar
  43. 43.
    Githin N, Ginn P, Kobayashi K, et al. The relationship between plasma cortisol and gastric mucosa prostaglandin levels in rats with stress ulcers. Aliment Pharmacol Ther 1988; 2:213–220.Google Scholar
  44. 44.
    Konturek SJ, Brzozowski T, Majka J, et al. Adaptation of the gastric mucosa to stress. Scand J Gastroenterol 1992;27(Suppl 193):39–45.Google Scholar
  45. 45.
    Brzozowski T, Konturek SJ, Drozdowicz D, et al. Gastric adaptation to stress. Role of sensory nerves, prostaglandins and epidermal growth factor. Eur J Pharmacol 1994; 253:107–114.PubMedGoogle Scholar
  46. 46.
    Glavin GB, Lockhart LK, Rockman GE, et al. Evidence of “cross-stressor”-induced adaptive gastric cytoprotection. Life Sci 1987;41:2223–2227.PubMedGoogle Scholar
  47. 47.
    Guth PH, Mendic R. The effect of chronic restraint stress on gastric ulceration in the rat. Gastroenterology 1964; 46:285–286.PubMedGoogle Scholar
  48. 48.
    Szolcsanyi J, Bartho L. Impaired defense mechanism to peptic ulcer in the capsaicin-desensitized rat. In: Mozsik Gy, Hanninen O, Javor T (eds) Gastrointestinal defense mechanism. Oxford and Budapest: Pergamon Press and Academia Kidao, 1981;39–51.Google Scholar
  49. 49.
    Brzozowski T, Majka J, Drozdowicz D, et al. Studies on gastroprotection induced by capsaicin and papaverine in rats. J Physiol Pharmacol 1992;43:309–322.PubMedGoogle Scholar
  50. 50.
    Holzer P, Sametz W. Gastric mucosal protection against ulerogenic factors in the rat mediated by capsaicin- sensitive afferent neurons. Gastroenterology 1986;91:975–987.PubMedGoogle Scholar
  51. 51.
    Holzer P, Lippe IP. Stimulation of nerve endings by intragastric capsaicin protects against ecthanol-induced damage of gastric mucosa. Neurosci 1988;27:981–987.CrossRefGoogle Scholar
  52. 52.
    Holzer P, Pabst MA, Lippe IT. Intragastric capsaicin protects against aspirin-induced lesion formation and bleeding in the rat gastric mucosa. Gastroenterology 1989;96:1425–1433.PubMedGoogle Scholar
  53. 53.
    Holzer P. Local effector functions of capsaicin-sensitive sensory nerve endings: Involvement of tachykinins, calcitonin gene-related peptide and other neuropeptides. Neurosci 1988; 24:739–768.CrossRefGoogle Scholar
  54. 54.
    Holzer P, Peskar BM, Peskar BA, et al. Release of calcitonin gene-related peptide induced by capsaicin in the vascularly perfused rat stomach. Neurosci Lett 1990;180:195–200.Google Scholar
  55. 55.
    Jancso G, Kiraly E, Jancso-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurons. Nature 1977;270:741–743.PubMedGoogle Scholar
  56. 56.
    Holzer P, Lippe IT, Raybould HE, et al. Role of peptidergic sensory neurons in gastric mucosal blood flow and protection. Ann NY Acad Sci 1991;632:272–282.PubMedGoogle Scholar
  57. 57.
    Evangelista S, Maggi CA. Protection induced by cholecystokinin-8 (CCK-8) in ethanol-induced gastric lesions is mediated via vagal capsaicin-sensitive fibers and CCK receptors. Br J Pharmacol 1991;102:119–122.PubMedGoogle Scholar
  58. 58.
    Holzer P, Sametz W. Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology 1986;91:975–987.PubMedGoogle Scholar
  59. 59.
    Uchida M, Yano S, Watanable K. Aggravation by the capsaicin treatment of gastric antral ulcers induced by the combination of 2-deoxy-D-glucose, aspirin and ammonia in rats. Jpn J Pharmacol 1991;57:377–385.PubMedGoogle Scholar
  60. 60.
    Geppetti P, Frilli S, Renzi D, et al. Distribution of calcitonin gene-related peptide-like immunoreactivity in various rat tissues: Correlation with substance P and other tachykinins and sensitivity to capsaicin. Reg Pept 1988;23:289–298.CrossRefGoogle Scholar
  61. 61.
    Sterini C, Reeve JR, Brecha N. Distribution and characterization of calcitonin gene-related peptide immunoreactivity in the digestive system of normal and capsaicin-treated rats. Gastroenterology 1987;93:852–862.Google Scholar
  62. 62.
    Lippe IT, Lerbach M, Holzer P. Close arterial infusion of calcitonin gene-related peptide into the rat stomach inhibits aspirin and ethanol-induced hemorrhagic damage. Reg Pept 1989;26:35–46.CrossRefGoogle Scholar
  63. 63.
    Maggi CA, Evangelista S, Giuliani S, et al. Anti-ulcer activity of calcitonin gene-related peptide in rats. Gen Pharmacol 1987;18:33–34.PubMedGoogle Scholar
  64. 64.
    Lenz HJ, Mortrud MT, Rivier JE, et al. Calcitonin gene-related peptide inhibits basal, pentagastrin, histamine and betanechol-stimulated gastric acid secretion. Gut 1985;26: 550–555.PubMedGoogle Scholar
  65. 65.
    Leung FW, Tallos EG, Tache YF, et al. Calcitonin gene-related peptide inhibits acid secretion without modifying blood flow. Am J Physiol 1987;252:G215-G218.PubMedGoogle Scholar
  66. 66.
    Hase T, Anderson RP, Mehlman B. Significance of gastric secretory changes in the pathogenesis of tress ulcer. Am J Dig Dis 1976;20:1197–1198.Google Scholar
  67. 67.
    Hayase M, Takeuchi K. Gastric acid secretion and lesion formation in rats under water-immersion stress. Dig Dis Sci 1986;31:166–171.CrossRefPubMedGoogle Scholar
  68. 68.
    Wright NA, Pike Ch, Elia G. Induction of a novel epidermal growth factor secreting cell lineage by mucosal ulceration in human gastrointestinal stem cells. Nature 1990;343:82–85.PubMedGoogle Scholar
  69. 69.
    Tarnawski A, Stachura J, Durbin T, et al. Expression of epidermal growth factor receptor in rat gastric oxyntic mucosa. J Clin Gastroenterol 1991;13(Suppl 1):S109-S113.PubMedGoogle Scholar
  70. 70.
    Polk WH, Dempsey PJ, Russall WE, et al. Increased production of transforming growth factor alpha following acute gastric injury. Gastroenterology 1992;102:1467–1471.PubMedGoogle Scholar
  71. 71.
    Robert A, Lancaster C, Olafsson AS, et al. Gastric adaptation to repeated administration of a necrotizing agent. In: Garner A, O'Brien PE (eds) Mechanism of injury, protection and repair of the upper gastrointestinal tract. Chichester: Wiley, 1991;357–370.Google Scholar
  72. 72.
    Whittle BJR, Lopez-Belmonte J, Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: Interactions with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 1990;99:607–611.PubMedGoogle Scholar
  73. 73.
    Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524–526.CrossRefPubMedGoogle Scholar
  74. 74.
    Moncada S, Palmer RM, Higgs EA. The discovery of nitric oxide as the endogenous nitrovasodilator. Hypertension 1988; 12:365–372.PubMedGoogle Scholar
  75. 75.
    Palmer RMJ, Rees DD, Moncada S.l-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 1988;153:1251–1256.CrossRefPubMedGoogle Scholar
  76. 76.
    Brown JF, Tepperman BL, Hanson PJ, et al. Differential distribution of nitric oxide synthase between cell fractions isolated from rat gastric mucosa. Biochem Biophys Res Commun 1992;30:680–685.Google Scholar
  77. 77.
    Peskar BM, Respondek M, Muller KM, et al. A role for nitric oxide in capsaicin-induced gastroprotection. Eur J Pharmacol 1991;198:113–114.CrossRefPubMedGoogle Scholar
  78. 78.
    Ishii KB, Chang JF, Kerwin J, et al. NG-nitro-l-arginine: A potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol 1990;176:219–221.PubMedGoogle Scholar
  79. 79.
    Moore PK, Al-Swayeh NWS, Evans RA, et al.l-NG-nitro-arginine (l-NOARG), a novel,l-arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro. Br J Pharmacol 1990;99:408–411.PubMedGoogle Scholar
  80. 80.
    MacNaughton WK, Cirino G, Wallace JL. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 1989;45:1869–1876.CrossRefPubMedGoogle Scholar
  81. 81.
    Kitagawa H, Takeda F, Kohei H. Gastric mucosal protective actions of endothelium-derived relaxing factor. Scand J Gastroenterol 1989;24(Suppl 162):S131-S133.Google Scholar
  82. 82.
    Lopez-Belmonte J, Whittle BJR, Moncada S. The actions of nitric oxide donors in the prevention or induction of injury to the rat gastric mucosa. Br J Pharmacol 1993;408:73–78.Google Scholar
  83. 83.
    Konturek SJ, Brzozowski T, Majka J, et al. Role of nitric oxide and prostaglandins in sucralfate-induced gastro-protection. Eur J Pharmacol 1992;27:161–163.Google Scholar
  84. 84.
    Konturek SJ, Brzozowski T, et al. Nitric oxide in gastroprotection by aluminum-containing antacids. Eur J Pharmacol 1992;229:155–162.CrossRefPubMedGoogle Scholar
  85. 85.
    Guth PH, Leung FW. Physiology of gastric circulation. In: Johnson LR (ed) Physiology of gastrointestinal tract. New York: Raven 1987;1031–1053.Google Scholar
  86. 86.
    Holm L. Gastric mucosal blood flow and mucosal protection. J Clin Gastroenterol 1989;10(Suppl 1):114–119.Google Scholar
  87. 87.
    Hui WM, Chen BW, Cho CH, et al. Role of gastric mucosal blood flow in cytoprotection. Digestion 1991;48:113–120.PubMedGoogle Scholar
  88. 88.
    John DJB, Yeomans ND, McDermott FT, et al. Adaptation of the gastric mucosa to repeated administration of aspirin in the rat. Am J Dig Dis 1973;18:881–886.CrossRefGoogle Scholar
  89. 89.
    Bolton JP, Cohen MM. Effect of repeated aspirin administration on gastric mucosal barrier and cell turnover. J Surg Res 1977;23:251–256.CrossRefPubMedGoogle Scholar
  90. 90.
    Kuwayama H, Eastwood GL. Effects of water immersion restraint stress and chronic indomethacin ingestion on gastric antral and fundic epithelial proliferation. Gastroenterology 1985;88:362–365.PubMedGoogle Scholar
  91. 91.
    Shorrock CJ, Prescott RJ, Rees WDW. The effect of indomethacin on gastroduodenal morphology and mucosal pH gradient in the healthy human stomach. Gastroenterology 1990;99:334–339.PubMedGoogle Scholar
  92. 92.
    Shorrock CJ, Rees RWD. Mucosal adaptation to indo methacin-induced gastric damage in man-studies on morphology, blood flow and prostaglandin E2 metabolism. Gut 1992;33:164–169.PubMedGoogle Scholar
  93. 93.
    Levi S, Goodlad RA, Chung YL, et al. Effects of nonsteroidal anti-inflammatory drugs and misoprostol on gastroduodenal epithelial proliferation in arthritis. Gastroenterology 1992; 102:1605–1612.PubMedGoogle Scholar
  94. 94.
    Konturek SJ, Brzozowski T, Stachura J, et al. Role of neutrophils and mucosal blood flow in gastric adaptation to aspirin. Eur J Pharmacol 1994;253:107–114.CrossRefPubMedGoogle Scholar
  95. 95.
    Konturek SJ, Konturek JW. Gastric adaptation. Basic and clinical aspects. Digestion 1994;55:131–138.PubMedGoogle Scholar
  96. 96.
    Brzozowski T, Majka J, Konturek SJ, et al. Adaptation of gastric mucosa to stress or aspirin (ASA). Role of sensory nerves prostaglandins (PG) and epidermal growth factor (EGF) (abstract). Gastroenterology 1993;104:A48.Google Scholar
  97. 97.
    Brzozowski T, Drozdowize D, Stachura J, et al. Gastric mucosa adapted to aspirin (ASA) or stress is more resistant to the damage induced by strong irritants (abstract). Gastroenterology 1994;106:A58.Google Scholar
  98. 98.
    Romano M, Gugliette A, Lesch CA, et al. Role of transforming growth factor-alpha (TGF-α) and epidermal growth factor (EGF) in the gastric adaptation to aspirin in monkeys and rats. Gastroenterology 1994;106:A836.Google Scholar
  99. 99.
    Menguy R. The prophylaxis of stress ulceration. N Engl J Med 1980;302:461–469.PubMedGoogle Scholar
  100. 100.
    Lanza FL. Endoscopic studies of gastric and duodenal injury after the use of ibuprophen, aspirin and other nonsteroidal matory agents Am J Med 1984;17(Suppl 20):12–19.Google Scholar
  101. 101.
    Lanza FL. A review of muscosal protection by synthetic prostaglandin E analogues against injury by nonsteroidal anti-inflammatory drugs. Scand J Gastroenterol 1989;24(Suppl 163):36–43.Google Scholar
  102. 102.
    Metzger WH, McAdam L, Bluestone R, et al. Acute gastric mucosal injury during continuous or interrupted aspirin ingestion in humans. Dig Dis 1976;21:963–968.Google Scholar
  103. 103.
    Konturek J, Dembiński A, Stoll R. et al. Gastric mucosal blood flow and neutrophil activation in aspirin-induced gastric mucosal damage in man. Scand J Gastroenterol 1993;28: 767–771.PubMedGoogle Scholar
  104. 104.
    Stachure J, Konturek J, Dembinski A, Demschke W. Growth markers in the human gastoric mucosa during adaptation to continued aspirin administration. Patol Pol (in press)Google Scholar
  105. 105.
    Bluch RF, Carpenter HA, Pittelkow MR, et al. Immunolocalization of transforming growth factor α in normal and diseased human gastric mucosa. Gastroenterology 1993; 104:A814.Google Scholar
  106. 106.
    Dempsey PJ, Goldenring JR, Soroka CJ, et al. Possible role of transforming growth factor α in the pathogenesis of Menetrier's disease: Supportive evidence from human and transgenic mice. Gastroenterology 1992;103:1950–1963.PubMedGoogle Scholar
  107. 107.
    Shah K, Price AB, Talbot IC, et al. Misoprostol selectively reduces the prevalence of histological reactive gastritis in patients on long-term NSAIDs. Gastroenterology 1994;106: A5.Google Scholar
  108. 108.
    Bielicki D, Markiewski M, Marlicz K, et al. PCNA/Cyclin defined proliferative activity of epithelial cells in normal gastric mucosa and in chronic gastritis. Patol Pol 1993;44: 75–78.PubMedGoogle Scholar
  109. 109.
    Ishikawa T, Tarnawski A, Sarfeh IJ, et al. Epidermal growth factor protects gastric mucosa against ischemia-reperfusion injury. J Clin Gastroenterol 1993;17(Suppl 1):S104-S110.PubMedGoogle Scholar
  110. 110.
    Eastwood G, Quimby G. Effect of chronic aspirin ingestion on epithelial proliferation in rat fundus, antrum and duodenum. Gastroenterology 1982;82:852–856.PubMedGoogle Scholar
  111. 111.
    Logan RE, Little J, Hawtin PG, et al. Effect of aspirin and non-steroidal anti-inflammatory drugs on colorectal adenomas: Case-control study of subjects participating in the Nottingham faecal occult blood screening programme. Br Med J 1993; 307:285–289.Google Scholar
  112. 112.
    Koztowski W, Kula Z, Kulig A, et al. Chronic erosive gastritis on morphological analysis. Patol Pol 1994;45:139–144.Google Scholar

Copyright information

© Springer-Verlag 1995

Authors and Affiliations

  • Jerzy Stachura
    • 1
    • 2
    • 3
  • Stanisław J. Konturek
    • 1
    • 2
    • 3
  • Tomasz Brzozowski
    • 1
    • 2
    • 3
  • Jan Konturek
    • 1
    • 2
    • 3
  • Wolfram Domschke
    • 1
    • 2
    • 3
  1. 1.Department of Pathomorphology, Faculty of MedicineJagellonian UniversityKrakówPoland
  2. 2.Department of Physiology, Faculty of MedicineJagellonian UniversityKrakówPoland
  3. 3.Department of Medicine BUniversity of MunsterGermany

Personalised recommendations